APA (7th ed.) Citation

B, N., R, S., NH, R., PH, F., SE, Y., S, C., . . . TH, D. (2026). Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial. Annals of surgical oncology, 33(1), 415. https://doi.org/10.1245/s10434-025-18432-0

Chicago Style (17th ed.) Citation

B, Nakamura, et al. "Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial." Annals of Surgical Oncology 33, no. 1 (2026): 415. https://doi.org/10.1245/s10434-025-18432-0.

MLA (9th ed.) Citation

B, Nakamura, et al. "Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial." Annals of Surgical Oncology, vol. 33, no. 1, 2026, p. 415, https://doi.org/10.1245/s10434-025-18432-0.